Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules – Effective Acid Reflux Control with Enhanced Gastric Motility.
CANALI DSR Capsules: The Dual composition of Rabeprazole 20 mg (Enteric Coated + Domperidone 30 mg (Sustained Release) is effectively treats acid reflux, GERD, and motility disorders:
Rabeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production by inhibiting the H+/K+ ATPase pump, preventing acid reflux, heartburn, and ulcer formation.
Domperidone is a prokinetic agent that accelerates gastric emptying and prevents acid regurgitation, reducing bloating, nausea, and reflux symptoms.
Recommended By Specialists:
Gastroenterologist: It is mainly used to prefer this combination to treat chronic acid reflux, GERD, erosive esophagitis, and delayed gastric emptying
General Physicians: It mainly differs in the treatment of diseases associated with acid-peptic disorders, indigestion, and nausea-related complaints
Key Benefits of Rabeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules – CANALI DSR Capsules:
Dual-Action for Acid Suppression & Gastric Motility – Rabeprazole controls excessive acid secretion, while Domperidone enhances gastric emptying, reducing acid reflux and bloating.
Superior to PPIs Alone – Addresses both acid-related disorders and motility dysfunction, providing comprehensive relief from GERD and dyspepsia.
Sustained-Release Formula for Long-Lasting Effect – Ensures extended symptom relief, reducing the need for frequent dosing and enhancing patient compliance.
INDICATIONS:
Gastroesophageal Reflux Disease (GERD)
Acid Peptic Disorders
Chronic Dyspepsia
Delayed Gastric Emptying
Recurrent Nausea & Bloating